Open Access 03-01-2024 | Entrectinib | Correction
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
Published in: Oncology and Therapy | Issue 1/2024
Login to get access